79922 Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–22476 Filed 9–30–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–24–1046; Docket No. CDC–2024– 

0074] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled National Breast 

and Cervical Cancer Early Detection 

Program (NBCCEDP) Monitoring 

Activities. This data collection is 

designed to systematically collect 

information about implementation, 

including delivery of screening and 

follow-up clinical services, and 

outcomes of the National Breast and 

Cervical Cancer Early Detection Program 

(NBCCEDP). 

DATES: CDC must receive written 

comments on or before December 2, 

2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0074 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Breast and Cervical Cancer 

Early Detection Program (NBCCEDP) 

Monitoring Activities (OMB Control No. 

0920–1046, Exp. 03/31/2025)— 

Revision—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

CDC is requesting a Revision of the 

information collection titled National 

Breast and Cervical Cancer Early 

Detection Program (NBCCEDP) 

Monitoring Activities (OMB Control No. 

0920–1046). The information collection 

consists of an annual NBCCEDP survey, 

baseline and annual clinic-level data 

collection, a quarterly program update 

(QPU) tool, a service delivery projection 

worksheet, and minimum data elements 

(MDEs). CDC proposes revisions to the 

Annual NBCCEDP Survey, clinic-level 

data collection tool and QPU, and 

continued use of the service delivery 

projection worksheet and MDEs with no 

changes. The number of respondents 

will increase from 70 to 71 and the total 

estimated annualized burden will 

decrease from 1,220 hours to 1,162 

hours. 

Breast and cervical cancers are 

prevalent among U.S. women. In 2021, 

the U.S. experienced 272,454 new cases 

and 42,211 deaths as a result of breast 

cancer, as well as 12,536 new cases and 

4,051 deaths as a result of cervical 

cancer. Evidence shows that deaths 

from both breast and cervical cancers 

can be avoided by increasing screening 

services—mammography, pap, and 

human papillomavirus (HPV) tests— 

among women. However, in 2021, 

approximately one quarter of adults 

were not up to date with breast and/or 

cervical cancer screening, and screening 

was underutilized among women who 

are under- or uninsured, have no regular 

source of healthcare, or who recently 

immigrated to the U.S. As a 

longstanding priority within chronic 

disease prevention, CDC focuses on 

increasing access to these cancer 

screenings, particularly among women 

who may be at increased risk. 

To improve access to cancer 

screening, Congress passed the Breast 

and Cervical Cancer Mortality 

Prevention Act of 1990 (Pub. L. 106– 

354), which directed CDC to create the 

National Breast and Cervical Cancer 

Early Detection Program (NBCCEDP). 

The NBCCEDP currently provides 

funding to 71 recipients under ‘‘Cancer 

Prevention and Control Programs for 

State, Territorial, and Tribal 

Organizations (DP22–2202).’’ NBCCEDP 

awardees include states or their bona 

fide agents; U.S. territories; and tribes or 

tribal organizations. The purpose of 

NBCCEDP is to increase breast and 

cervical cancer screening rates among 

women residing within defined 

geographical locations (as determined 

by the funded program) who are at or 

below 250% of the federal poverty level; 

aged 50–75 years for breast cancer 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 79923 

services, and aged 21–64 years for 

cervical cancer services; and under- or 

uninsured. 

CDC proposes revisions to three of the 

previously approved information 

collection instruments: 

Annual NBCCEDP Survey—This 

instrument collects program-level 

information annually to monitor 

recipients’ challenges, external funding 

sources, partnerships, and EBI 

implementation. The survey has been 

revised to include new survey questions 

to improve data quality for items related 

to partnership activities and recipients’ 

requirements for patients’ payments 

towards screening services, as well as 

the removal of a COVID–19 related 

question. 

Clinic-Level Data Collection Tool— 

This instrument collects clinic-level 

data at baseline and annually to assess 

health system, clinic, and patient 

population characteristics; monitoring 

and quality improvement activities; EBI 

implementation; and baseline or annual 

screening rates. This tool has been 

revised to remove COVID–19 related 

variables and update response options 

for the measures used to report breast 

and cervical cancer screening rates. 

QPU—This instrument collects 

program-level data four times per year 

to monitor award spending, service 

delivery, staff vacancies, program 

challenges and successes, and TA 

needs. This instrument has been revised 

to include two optional open-ended 

items to allow recipients to provide 

context to reported service delivery and 

spending data only if needed. 

CDC proposes continued use of the 

remaining two information collections; 

Service Delivery Project Worksheet and 

the MDEs, which have not been 

changed. To maximize consistency in 

our routine data collections for the 

current NBCCEDP funding cycle, CDC 

has not revised NBCCEDP information 

collections to align with the Department 

of Health and Human Services (HHS)’ 

current best practices for demographic 

questions related to sexual orientation 

and gender identity (SOGI) and race and 

ethnicity (R/E) at this time. However, 

CDC plans to revise information 

collections that include demographic 

items to align with HHS’ SOGI and R/ 

E guidelines for the next funding cycle 

beginning in 2027. 

The proposed information collections 

will allow CDC to better gauge progress 

in meeting NBCCEDP program goals and 

monitor implementation activities, 

evaluate outcomes, and identify 

awardee technical assistance needs. In 

addition, findings will inform program 

improvement and help identify 

successful activities that need to be 

maintained, replicated, or expanded. 

OMB approval is requested for three 

years. CDC requests OMB approval for 

an estimated 1,162 annual burden 

hours. Participation is required for 

NBCCEDP awardees. There are no costs 

to respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

NBCCEDP Awardees ....................... Annual NBCCEDP Survey ............... 71 1 46/60 54 

NBCCEDP Clinic-level Information 

Collection Instrument—Breast.

71 6 40/60 284 

NBCCEDP Clinic-level Information 

Collection Instrument—Cervical.

71 6 40/60 284 

Quarterly Program Update ............... 71 4 22/60 151 

Service Delivery Projection Worksheet.71 1 29/60 34 

MDEs ................................................ 71 2 150/60 355 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,162 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–22477 Filed 9–30–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day—24–24IW; Docket No. CDC–2024– 

0070] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Becton 

Dickinson BACTECTM Blood Culture 

Media Bottles Shortage Impact 

Questionnaire, which will assess the 

impact of the Becton Dickinson (BD) 

BACTECTM blood culture media bottles 

supply shortage on individual facilities 

and how CDC NHSN bloodstream 

infection surveillance might be affected. 

DATES: CDC must receive written 

comments on or before December 2, 

2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0070 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 


khammond on DSKJM1Z7X2PROD with NOTICES